Moderna COVID-19 Vaccine Protection May Last Years, Company Claims
CDC recommends people who have already had the virus also receive the vaccine as reinfection is possible
Perception of Not Returning to Full Health Common After COVID-19
47 percent experience fatigue, with no correlation between any measures of persistent disease and initial disease severity
Early High-Titer Plasma Reduces Progression of COVID-19
Early administration of high-titer convalescent plasma against SARS-CoV-2 reduces progression in mildly ill older adults
Laws Promoting Flu Shot for Hospital Workers Can Cut Deaths
2.5 percent drop seen in monthly pneumonia, flu mortality rates with implementation of state laws requiring hospitals to offer flu shot
Many Dialysis Patients Report Proficiency in Mobile Health
Older patients have lower mobile health proficiency, as do those with Hispanic/Latinx ethnicity, less than college education
Review Confirms Interarm SBP Difference, Mortality Link
All-cause mortality risk increased with interarm systolic blood pressure difference magnitude from ≥5 mm Hg threshold
Majority of SARS-CoV-2 Transmission Due to Asymptomatic Individuals
In base case of modeling study, 59 percent of transmission attributed to presymptomatic and asymptomatic individuals
Vitamins E, C Inversely Linked to Risk for Parkinson Disease
Comparing individuals in highest versus lowest tertile of exposure, inverse link seen for both vitamins C and E; no link for beta-carotene, NEAC
Allergists Affirm Safety of COVID-19 Vaccines for Most
All patients should be observed for 15 minutes after vaccination; staff should be trained in anaphylaxis management
11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported
Median interval from vaccine receipt to symptom onset was 13 minutes
